Atlas Trials

to Assess the Eradication Rate of 14-day Bismuth/Amoxicillin/PCAB Triple Therapy for the Treatment of Helicobacter Pylori Infection

Clinical trial NCT07142798 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07142798
Sponsor
Kaohsiung Medical University
Status
ENROLLING_BY_INVITATION
Phase
Not Applicable
Study type
INTERVENTIONAL
HELICOBACTER PYLORI INFECTIONS
Start date
2024-09-26
Primary completion
2025-12-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.